Subject: National Prescription Opiate Litigation From: Office Of The City Attorney Recommendation: Adopt A Resolution Authorizing The City Attorney To: (1) Release The City’s Potential Claims As Necessary To Join Eight National Settlement Agreements With Opioid Manufacturers Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, And Zydus, And The Accompanying California State-Subdivision Agreements; And (2) Release The City’s Claims Against Purdue Pharma And Sackler Entities As Necessary To Consent And Participate In The Accompanying Bankruptcy Plan And Settlement Agreements (Office Of The City Attorney - Public Nuisance, False Advertising, Unfair Competition)

Committee

* Concurrent Meeting of the Oakland Redevelopment Successor Agency and the City Council

Requested by

Office Of The City Attorney

Introduced

September 24, 2025

On agenda

October 7, 2025

Passed

October 7, 2025

Enactment no.

90879 C.M.S

Where it was heard

* Concurrent Meeting of the Oakland Redevelopment Successor Agency and the City Council Oct 7, 2025 Adopted Pass *Rules & Legislation Committee Sep 25, 2025 Scheduled